Skip to content

Apyx Medical Corporation APYX Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Artivion logo
ArtivionAORT
$1.25M-70.1%
AngioDynamics logo
AngioDynamicsANGO
$716K-20.0%
AIR
AirSculpt Technologies, Inc.AIRS
$14.59M
PROCEPT BioRobotics Corporation logo
PROCEPT BioRobotics CorporationPRCT
$222K-82.9%
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
$1.67M+341%
Haemonetics logo
HaemoneticsHAE
$1.15M+127%

Other financials

Income statement

See full
Revenue$12.5M+32.4%
Gross profit$7.5M-19.2%
Operating income-$5.5M-349%
Net income-$2.1M+48.6%
EPS (diluted)-$0.19-533%

Balance sheet

See full
Cash & equivalents$31.1M+0.4%
Total debt$39.5M+1.4%
Total equity$12.8M+22.1%
Total assets$63.0M+4.8%

Cash flow

See full
Operating cash flow-$572.0K+18.5%
CapEx$60.0K+9.1%
Free cash flow-$632.0K+16.5%

Valuation

See full
Market cap$181.07M+114%
Enterprise value$189.4M+101%
P/S3.2×+1.4×

Profitability

See full
Gross margin61.9%-3.1pp
Operating margin-46%+9.9pp
Net margin-16.2%-6.2pp
FCF margin-16.1%-4.8pp

Returns & leverage

See full
Return on equity-77.8%-22.4pp
Debt / equity3.1×-0.6×
Current ratio5.8×+0.3×

Where this comes from

Reported directly by Apyx Medical Corporation in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Apyx Medical Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apyx Medical Corporation's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Apyx Medical Corporation's stock issuance proceeds?
Apyx Medical Corporation (APYX) reported stock issuance proceeds of $88K in Q1 2026.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.